Trusted analytics from molecule to market
Lunar Labs Ltd — UK Contract Testing Laboratory

GMP-grade testing for Pharma Products Nutra Brands Food Innovators

Lunar Labs is a UK contract testing laboratory designed to MHRA and EU GMP standards. From early-phase R&D and stability studies through routine release of commercial product, our analysts, scientists and quality team support pharmaceutical, nutraceutical, food and veterinary clients across the UK and EU — under one roof, one quality system.

  • Designed to MHRA & EU GMP
  • ICH-Aligned Methods
  • Single Point of Contact
  • Dossier-Ready Reports
Pharmaceutical testing — HPLC instrument and vials
Pillar 01 · Pharmaceutical Testing

GMP Contract Testing

Method development, validation and routine release. ICH Q1A stability, USP / Ph. Eur. / BP methods, microbiology and endotoxin under one roof.

Explore Pharma Testing →
Nutraceutical and food testing — supplement jar and capsules
Pillar 02 · Nutraceutical & Food

Supplement & Food Testing

Identity, potency, label-claim verification, allergen management and contaminants — pharma-grade rigour applied to nutra and food brands.

Explore Nutra & Food →
Quality and regulatory — dossier with shield and stamp
Pillar 03 · Quality & Regulatory

Dossier-Ready Reporting

Specifications, validation, OOS investigation and dossier authoring written for MHRA and EU GMP. eCTD Module 3 and FSA / EFSA novel-food packages.

Explore Quality & Regulatory →
5–10Day Turnaround
4Service Pillars
UKPark Royal, London
ICHQ1A · Q2 · Q6A
MHRA Application Submitted
EU GMP Aligned
ICH-Aligned Methods
Inspection-Ready Data
UK-Based, UK-Operated
UK
Park Royal, London
MHRA
Application In Progress
ICH
Q1A · Q2 · Q6A Aligned
4
Lifecycle Phases Supported
Lab bench with HPLC, microscope and test tubes
About Lunar Labs Ltd

A UK contract laboratory built around regulatory clarity, not jargon.

Lunar Labs exists to give pharmaceutical, nutraceutical and food clients straightforward access to regulator-grade analytical work without the friction. Our laboratory operations, methods and quality system are designed to meet MHRA and EU GMP expectations. Our MHRA licence application is currently under review, and we will publish licence details on this site as soon as authorisation is granted.

  • Pharma, nutra, food and veterinary samples — one laboratory, one quality system
  • ICH-aligned method development, validation and transfer
  • Reports written for inclusion in regulatory dossiers
More About Us
What We Do

Four pillars. One laboratory.

From method development through to commercial release — we cover the analytical, microbiological, regulatory and consultancy work that pharma, nutra and food clients need.

Pharmaceutical Testing

GMP contract testing, stability, raw materials & API analysis, microbiology — designed to MHRA and EU GMP standards.

  • USP / Ph. Eur. / BP methods
  • ICH Q1A stability programmes
  • Bioburden, sterility, endotoxin
Learn more →

Nutra & Food

Dietary supplement and natural products testing, nutritional labelling, food safety, allergen management and shelf-life work.

  • Label-claim verification
  • 14 regulated allergens
  • Heavy metals, mycotoxins
Learn more →

R&D & Reformulation

Product development, reformulation for cost or stability, ingredient research and analytical method development.

  • Concept-to-launch support
  • ICH Q2 method validation
  • Method transfer to clients
Learn more →

Quality & Regulatory

MHRA & EU GMP-aligned quality support, regulatory submissions, novel-food dossiers and life-science training.

  • eCTD Module 3 support
  • Specification design
  • Bespoke client-site training
Learn more →

View All Services

Wherever You Are in the Lifecycle

Discovery → Preclinical → Clinical → Commercial

We tailor depth, documentation and turnaround to the phase your programme is in. Pick a phase and see how we plug in.

1

Research & Discovery

Early characterisation, screening assays, ingredient comparability and feasibility work. Light documentation, fast turnaround.

Learn more →
2

Preclinical

Formulation characterisation, dose verification and impurity profiling ahead of regulated GLP studies and IND/CTA submissions.

Learn more →
3

Clinical Development

IMP release, stability, comparator characterisation and ICH Q2 method validation for Phase I, II and III materials.

Learn more →
4

Manufacturing & Commercialisation

Routine release, ongoing stability monitoring, change-control support and post-marketing surveillance analytics.

Learn more →
Industries We Serve

By Molecule, Product Type & Sector

How We Engage

Five steps from brief to dossier

From your first call through to dossier-ready data — we keep every step clear, predictable and traceable.

1

Brief & Scope

A short conversation about the product, the regulator you answer to, and what success looks like for the study.

2

Protocol & Quote

You receive a written protocol, indicative timeline and itemised quote within one working day of agreed scope.

3

Sample Receipt & Method

Samples logged into the QMS. We run validated methods (or develop and validate new ones per ICH Q2) under documented control.

4

Analysis & QC Review

Analysts execute, second-analyst checks the raw data, Quality reviews and signs off the report against the agreed specification.

5

Report & Dossier Support

You receive a CoA or study report formatted for inclusion in your regulatory dossier — with the underlying raw data on file for inspection.

Why Lunar Labs

Designed for clients who answer to a regulator.

Six things our clients tell us they value most.

Designed to MHRA & EU GMP

Quality system, methods and documentation built to map onto MHRA and EU GMP expectations from day one.

ICH-Aligned Methods

Method development and validation against ICH Q2; stability against ICH Q1A; specifications against ICH Q6A.

Predictable Turnaround

Standard analytical batches typically return in 5–10 working days. Stability and validated method work runs on agreed protocol timelines.

Single Point of Contact

One scientist owns your file. Briefing, protocol, method, analysis and report come through the same person.

Dossier-Ready Reports

CoA, validation report, stability summary or investigation report — formatted for inclusion in regulatory submissions.

Training Built In

Need to upskill your QC team or train internal auditors on GMP? Our consultancy arm runs bespoke programmes alongside the lab work.

People We Work With

Every brief, a tailored study

No two clients are the same — and we don't pretend otherwise. Here are the profiles that walk through our door most often.

Drug-Product Manufacturers

Innovator and generic drug-product makers needing routine release, stability and impurity profiling against MHRA / EU GMP expectations.

Biotech & Sponsors

Sponsors progressing IMP through Phase I–III. We handle method validation, stability and IMP release on phase-appropriate documentation.

CDMOs & Contract Manufacturers

Independent analytical capacity for clients who need an arm's-length lab result — method transfer, batch release and stability programmes.

Nutraceutical Brands

DTC supplement brands and contract-manufactured ranges who want pharma-grade rigour applied to identity, potency and contaminants.

Food & Beverage Manufacturers

Food businesses needing FSA / EFSA-aligned safety, allergen management, nutritional labelling and shelf-life evidence.

Quality & Regulatory Teams

QA leads handling MHRA queries, OOS investigations or change-control packages who need an independent lab to back the data.

Regulatory Framework

Standards Our Work Maps Onto

We do not self-certify accreditation. The framework below describes the standards our methods, documentation and quality system are designed to align with.

MHRA
Application Submitted
EU GMP
EudraLex Vol. 4 — Aligned
ICH
Q1A · Q2 · Q6A · Q9
USP / Ph. Eur. / BP
Compendial Methods

Have a study to brief, or a method to validate?

Send us a one-paragraph description of what you need. We'll come back within one working day with a scope and indicative timeline.

Brief Us in 5 Minutes